FacialDx Launches HIPAA-Compliant AI Platform to Help Employers, Healthcare Systems, and Government Agencies Objectively Assess and Improve Workforce Wellness
ORANGE PARK, FL, UNITED STATES, March 4, 2026 /EINPresswire.com/ — FacialDx today announced a limited-time free trial of its AI-powered enterprise wellness platform designed to deliver objective, data-driven wellness insights across healthcare, corporate, government, military, and athletic performance sectors.
As organizations face rising healthcare costs, burnout, absenteeism, and productivity challenges, leaders are seeking measurable, privacy-conscious solutions that move beyond subjective surveys and self-reporting. FacialDx leverages artificial intelligence to provide rapid, non-invasive wellness assessments that help organizations identify risk trends, allocate resources more effectively, and support earlier intervention strategies.
Unlike traditional wellness tools that rely solely on questionnaires and “look and see” screening, FacialDx introduces objective measurement capabilities while maintaining strict privacy safeguards. The platform is fully HIPAA-compliant, enterprise pilot program ready, and designed to integrate seamlessly into existing workflows without disrupting operations.
Addressing a Growing Need Across Sectors: From hospitals managing clinician fatigue to corporations addressing workforce burnout, organizations are under pressure to balance performance with well-being. Government agencies and military units require scalable, secure tools to support readiness and resilience. Athletic programs seek performance optimization while safeguarding athlete health.
FacialDx enables leadership teams to gain objective wellness insights at scale, identify trends before they escalate into costly issues, reduce administrative time spent on manual assessments, support early intervention strategies and lower long-term healthcare and productivity-related costs. By providing fast, secure assessments, the platform helps decision-makers shift from reactive care models to proactive wellness strategies.
Enterprise-Grade Privacy and Compliance: Security and confidentiality remain central to the FacialDx platform. Built with HIPAA-compliant infrastructure, the system ensures protected health information is handled according to federal standards. Data is encrypted, securely stored, and accessible only through authorized channels.
Limited-Time Free Trial for Qualified Organizations: To accelerate adoption and demonstrate measurable impact, FacialDx is offering a complimentary enterprise trial to qualified organizations. The trial provides full platform access, onboarding support, and performance benchmarking tools to evaluate outcomes.
“Organizations deserve objective tools that empower leadership with actionable insights while protecting privacy,” said Doug Benoit, FacialDx CEO. “Our free trial allows decision-makers to evaluate how AI-driven wellness measurement can reduce costs, save time, and improve overall workforce resilience.”
FacialDx is an AI-powered enterprise wellness software platform focused on delivering objective, secure, and scalable wellness insights for healthcare systems, corporations, government agencies, and performance organizations. FacialDx is an American company committed to advancing data-driven well-being while maintaining the highest standards of privacy and compliance.
For more information or to request a free trial, visit www.facialdx.com. To create a free, secure account and try the app for free, visit https://app.facialdx.com
or contact:
Media Contact: Andrew Berz, Marketing Director
FacialDx
Email: andrew@facialdx.com
Doug Benoit
FacialDx
+1 727-966-3223
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
